GR900100569A - Μέ?οδος παρασκευής ενώσεως για χορήγηση δια του στόματος περιεχούσης NAC. - Google Patents

Μέ?οδος παρασκευής ενώσεως για χορήγηση δια του στόματος περιεχούσης NAC.

Info

Publication number
GR900100569A
GR900100569A GR900100569A GR900100569A GR900100569A GR 900100569 A GR900100569 A GR 900100569A GR 900100569 A GR900100569 A GR 900100569A GR 900100569 A GR900100569 A GR 900100569A GR 900100569 A GR900100569 A GR 900100569A
Authority
GR
Greece
Prior art keywords
nac
oral composition
preparing oral
preparing
composition
Prior art date
Application number
GR900100569A
Other languages
English (en)
Inventor
Angelo Carenzi
Dario Chiarino
Antonio Longo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of GR900100569A publication Critical patent/GR900100569A/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR900100569A 1989-07-27 1990-07-25 Μέ?οδος παρασκευής ενώσεως για χορήγηση δια του στόματος περιεχούσης NAC. GR900100569A (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8921339A IT1231012B (it) 1989-07-27 1989-07-27 Composizione farmaceutica per uso orale contenente nac.

Publications (1)

Publication Number Publication Date
GR900100569A true GR900100569A (el) 1991-12-10

Family

ID=11180335

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100569A GR900100569A (el) 1989-07-27 1990-07-25 Μέ?οδος παρασκευής ενώσεως για χορήγηση δια του στόματος περιεχούσης NAC.

Country Status (20)

Country Link
US (1) US5080906A (el)
JP (1) JPH0399012A (el)
KR (1) KR910002438A (el)
AU (1) AU625925B2 (el)
BE (1) BE1003188A4 (el)
CA (1) CA2021808A1 (el)
CH (1) CH680190A5 (el)
DE (1) DE4023774A1 (el)
DK (1) DK177890A (el)
FI (1) FI903759A0 (el)
FR (1) FR2650503B1 (el)
GB (1) GB2234171B (el)
GR (1) GR900100569A (el)
IE (1) IE902627A1 (el)
IL (1) IL95158A0 (el)
IT (1) IT1231012B (el)
NL (1) NL9001714A (el)
NZ (1) NZ234647A (el)
SE (1) SE9002500L (el)
ZA (1) ZA905861B (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
US5286480A (en) * 1992-06-29 1994-02-15 The Procter & Gamble Company Use of N-acetylated amino acid complexes in oral care compositions
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
GB9226729D0 (en) * 1992-12-22 1993-02-17 Wellcome Found Therapeutic combination
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
BE1007926A3 (fr) * 1994-01-31 1995-11-21 Zambon Int Pharma Composition pharmaceutique contenant de la n-acetyl-cysteine.
US6896899B2 (en) * 1996-12-31 2005-05-24 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
EP0957901B1 (en) 1996-12-31 2009-11-18 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
FR2803720B1 (fr) 2000-01-18 2004-10-22 Roquette Freres Lozenges a base de dextrose et leur procede de fabrication
US6114387A (en) * 2000-02-16 2000-09-05 Cutler; Paul Pharmaceutical composition for oral administration of chelating agents
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
US20030162732A1 (en) * 2001-07-05 2003-08-28 Astion Development A/S Combination of aminosugars and cysteine or cysteine derivatives
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20021881A1 (it) * 2002-09-04 2004-03-05 Zambon Spa Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato urinario.
US20050008699A1 (en) * 2003-07-11 2005-01-13 Fred Wehling Effervescent glucosamine composition
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
KR20050104152A (ko) * 2004-04-28 2005-11-02 최승호 경구용 약물의 흡수를 증진하는 약제학적 조성물
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
TR200900882A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
WO2018108960A1 (en) * 2016-12-15 2018-06-21 Zambon S.P.A. N-acetylcysteine for use as antibacterial agent
US20210260012A1 (en) * 2018-07-27 2021-08-26 I.C.F. Srl Compositions for the prevention and treatment of cutaneous affections

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2192790A (en) * 1986-07-24 1988-01-27 Inpharzam Int Sa Acetylcysteine compositions
EP0339508A1 (en) * 1988-04-29 1989-11-02 Altergon S.A. Mouth-soluble pharmaceutical compositions containing acetylcysteine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
US4877612A (en) * 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
US4894225A (en) * 1987-03-02 1990-01-16 Cetus Corporation Combination therapy using antitumor immunotoxins with tumor necrosis factor
JPS63290824A (ja) * 1987-05-22 1988-11-28 Sumitomo Chem Co Ltd ウイルス感染症治療剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2192790A (en) * 1986-07-24 1988-01-27 Inpharzam Int Sa Acetylcysteine compositions
EP0339508A1 (en) * 1988-04-29 1989-11-02 Altergon S.A. Mouth-soluble pharmaceutical compositions containing acetylcysteine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BIOLOGICAL ABSTRACTS, vol. 83, no. 1, 1987, abstract no. 7424, Biological Abstracts, Inc., Philadelphia, PA, US; N. SALTZMAN et al.: "Chemolysis of cystine calculi", & J. UROL. 136(4): 846-849. 1986 *
BIOLOGICAL ABSTRACTS, vol. 83, no. 1, 1987, abstract no. 7425, Biological Abstracts, Inc., Philadelphia, PA, US; J.R. BURNS et al.: "In vitro dissolution of cystine urinary calculi", & J. UROL. 136(4): 850-852. 1986 *

Also Published As

Publication number Publication date
IL95158A0 (en) 1991-06-10
NZ234647A (en) 1992-02-25
AU625925B2 (en) 1992-07-16
GB2234171B (en) 1993-11-10
JPH0399012A (ja) 1991-04-24
IT1231012B (it) 1991-11-08
DE4023774A1 (de) 1991-01-31
FR2650503A1 (fr) 1991-02-08
CA2021808A1 (en) 1991-01-28
SE9002500D0 (sv) 1990-07-26
SE9002500L (sv) 1991-01-28
IT8921339A0 (it) 1989-07-27
AU5993590A (en) 1991-01-31
DK177890A (da) 1991-01-28
FI903759A0 (fi) 1990-07-27
US5080906A (en) 1992-01-14
NL9001714A (nl) 1991-02-18
KR910002438A (ko) 1991-02-25
IE902627A1 (en) 1991-02-27
GB9016256D0 (en) 1990-09-12
DK177890D0 (da) 1990-07-26
GB2234171A (en) 1991-01-30
FR2650503B1 (fr) 1992-05-29
ZA905861B (en) 1991-07-31
BE1003188A4 (fr) 1992-01-07
CH680190A5 (el) 1992-07-15

Similar Documents

Publication Publication Date Title
EG19242A (en) Process for preparing oral compositions.
GR900100569A (el) Μέ?οδος παρασκευής ενώσεως για χορήγηση δια του στόματος περιεχούσης NAC.
GR900100568A (en) A method for preparing a composition in the form of microparticles
EP0411512A3 (en) Dental composition
EP0413290A3 (en) Material for dentistry
GR900100165A (en) Method for preparing sulfo-triazolo-diazepino-derivatives
GR890100769A (en) Method for preparing (s)-a-ethyl-2-oxo-1-pyrrolidineacetamide
GR862030B (en) Method for preparing pharmaceutical compositions
EP0411645A3 (en) Method for preparing organohalosilanes
GB8827899D0 (en) Compound composition process & use
GR900100319A (en) Novel thieno-triazolo-diazepino-derivatives preparation method
GR900100270A (en) Preparation method for 2-substituted n n-bitrimethoxybenzol-piperazines
GB8806531D0 (en) Dietary composition & process for preparing same
GR900100167A (en) Method for preparining sulfo-triazolo-diazepines sulfonylic derivatives
GR1002175B (en) Method for preparing solid compositions
GR900100491A (en) Acaricidel compositions and process for preparing same
GB8819444D0 (en) Spread & process for preparing spread
GB8824694D0 (en) New isopolypeptides & process for preparation thereof
HK123396A (en) New broncho-spasmolytic compounds and process for their preparation
GR900100364A (en) Method for preparating pharmaceutical compositions
GR900100777A (en) Improved method for useful diazinylpiperidines
GR3020992T3 (en) Method for the preparation of aminotriazin derivatives
GB8924295D0 (en) Oral compositions
BG46391A1 (en) Method for obtaining nuclear- poly- lump size virus composition
GR870422B (en) Method for preparing pharmaceutical compositions containing vinburnine